Samsung Seoul Hospital, Samsung Medical Center
Seoul, 135-710, South Korea
NCT Number: NCT01379313
In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure. The investigators tried to evaluate the effect of various inspiratory to expiratory ratio on pulmonary gas exchange by randomized controlled trial.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Seoul, 135-710, South Korea
In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure. During the laparoscopic surgery with abdominal gas insufflation, gas exchange disturbance such as CO2 retention, hypoxemia occurs in addition to high plateau airway pressure. The usual strategy against these kinds of problem is pressure-controlled ventilation. However, the gas exchange problem especially CO2 retention can not be solved in some cases. The inverse-ratio ventilation (IRV), which prolongs the inspiratory time greater than expiratory time, can be applied for adult respiratory distress syndrome. The efficacy of IRV is to improve gas-exchange status by increasing mean airway pressure and alveolar recruitment. There have been several clinical investigations which applied IRV during general anesthesia. However, there have been debates about the effect of IRV during general anesthesia. Therefore, we tried to apply the IRV for subjects undergoing laparoscopic surgery, and evaluate the effect of different I:E ratio on the pulmonary gas exchange and respiratory mechanics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
conventional I:E ratio of 1:2 is applied.
I:E ratio of 1:1 is applied.
Inverse I:E ratio of 2:1 is applied.
external positive end-expiratory pressure of 5 cmH2O is applied.
Time frame: 10 minutes after induction of general anesthesia
arteial CO2 partial pressure
Time frame: 30 minutes after start of pneumoperitoneum
arteial CO2 partial pressure
Time frame: 60 minutes after start of pneumoperitoneum
arteial CO2 partial pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
arterial O2 partial pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
Mean airway pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
tidal volume (setting)
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
systolic/ diastolic blood pressure, heart rate, mean blood pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
end-tidal CO2 partial pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
Dynamic compliance, Static compliance
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
physiologic dead space / tidal volume (VD/VT)
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
work of breathing
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
peak inspiratory pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
plateau pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
positive end-expiratory pressure
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
tidal volume (exhaled)
Time frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
minute ventilation
Samsung Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01937104
Adnexal Diseases, Biliary Tract Diseases
Gwangju, Donggu, South Korea
View Trial DetailsNCT02563392
Connective Tissue Diseases, Myofibroma
Geneva, Switzerland
View Trial DetailsNCT05086770
Connective Tissue Diseases, Leiomyoma
Seoul, South Korea
View Trial DetailsNCT05108597
Blood Loss, Surgical, Connective Tissue Diseases
Rawalpindi, Punjab Province, Pakistan
View Trial Details